SCHEDULE 13G/A: Capital Research Global Investors Discloses 3.8% Stake in Klaviyo, Inc.
Beneficial Ownership Report (Schedule 13G Amendment)
Capital Research Global Investors has filed an amended Schedule 13G, reporting beneficial ownership of 3.8% of Klaviyo, Inc.'s common stock as of December 31, 2024.
Summary
- Capital Research Global Investors (CRGI) has filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Klaviyo, Inc.
- As of December 31, 2024, CRGI beneficially owns 3,001,500 shares of Klaviyo, Inc. Common Stock.
- This ownership represents 3.8% of the total outstanding shares of Klaviyo, Inc., based on 78,803,963 shares believed to be outstanding.
- CRGI holds sole voting power over all 3,001,500 shares.
- CRGI also holds sole dispositive power over all 3,001,500 shares.
- CRGI is identified as an investment adviser (IA) and is a division of Capital Research and Management Company (CRMC) and its investment management subsidiaries and affiliates.
Sentiment
Score: 6
Explanation: The filing indicates a significant beneficial ownership by a major institutional investor, Capital Research Global Investors, which can be viewed as a vote of confidence, though the filing itself is a routine regulatory disclosure and does not provide new operational or financial insights.
Positives
- The disclosure of a significant stake by a major institutional investor like Capital Research Global Investors can be interpreted as a vote of confidence in Klaviyo, Inc.'s long-term prospects.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding Klaviyo, Inc.'s future performance or outlook.
Industry Context
This filing is a routine regulatory disclosure of beneficial ownership by an institutional investor, providing transparency on significant holdings within the public market. It does not offer insights into broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, which can offer insights into investor confidence.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (reporting period end date). |
| 02/11/2025 | Date the Schedule 13G Amendment No. 1 was signed and filed. |
Keywords
Klaviyo, Capital Research Global Investors, Schedule 13G, beneficial ownership, common stock, institutional investor, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.